Medtronic Inc

iCRco Inc. is a seasoned provider of advanced imaging systems, specializing in digital radiology solutions that enhance efficiency and quality in medical imaging. With over 2 billion images processed globally, the company has made significant contributions to various fields, including equine veterinary medicine and motion picture production, over its 35 years of operation. Their product offerings, such as the AirDR Digital Radiology system and Claris CBCT, demonstrate a commitment to innovation and reliability, enabling healthcare professionals to deliver essential services in diverse and challenging environments. iCRco's advanced mobile CT units also facilitate greater accessibility to diagnostic imaging, especially in underserved communities and emergency situations. Generated from the website

iCRco Inc. is a leading provider of advanced imaging solutions, specializing in the transition from Computed Radiology (CR) to Digital Direct Radiology (AirDR), enhancing efficiency and accessibility for medical facilities. With over 30 years of experience, the company offers innovative technologies including fully-mobile CT solutions and high-resolution Cone Beam Computed Tomography (CBCT) systems tailored for orthopedic and veterinary imaging. Committed to pioneering advancements in diagnostic imaging, iCRco has supported a diverse range of sectors, including equine veterinary care and archival restoration, while delivering over 2 billion images worldwide. Their state-of-the-art mobile imaging units and tele-radiology platforms are designed to improve patient care, especially in underserved or remote areas. Generated from the website

VBS Pharmaceuticals, located in Goleta, CA, specializes in developing innovative therapeutic solutions for serious diseases, particularly focusing on pulmonary hypertension, sepsis, and other vascular-related conditions. Their lead candidate, CARSKNKDC CAR peptide, aims to enhance treatment efficacy while minimizing systemic side effects by selectively targeting diseased tissues. The company also features the endoarterial biopsy catheter, the first device designed for minimally invasive biopsy sampling from artery inner layers, enabling better diagnosis and monitoring of vascular diseases. Alongside their interventional products, VBS is advancing molecular diagnostics to provide comprehensive analyses of vascular conditions, reflecting their commitment to improving patient care and outcomes. Generated from the website